REQUEST A DEMO
Total
USD $0.00
Search more companies

Provisus Badania Kliniczne Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Pharmacies and Drug Stores | Ambulatory Health Care Services | Offices of Physicians | Offices of Dentists | Offices of All Other Miscellaneous Health Practitioners | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services
Full name: Provisus Badania Kliniczne Sp. z o.o. Profile Updated: May 18, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Provisus Badania Kliniczne Sp. z o.o. is based in Poland. The head office is in Czestochowa. The enterprise operates in the General Medical and Surgical Hospitals industry. Provisus Badania Kliniczne Sp. z o.o. was incorporated on April 20, 2020. In its most recent financial highlights, the company reported a net sales revenue increase of 54.68% in 2023. Its’ total assets recorded a growth of 341.21%. The net profit margin of Provisus Badania Kliniczne Sp. z o.o. increased by 12.17% in 2023.

Headquarters
Ul. Redzinska 112
Czestochowa; Slaskie; Postal Code: 42-209

Contact Details: Purchase the Provisus Badania Kliniczne Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Provisus Badania Kliniczne Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Provisus Badania Kliniczne Sp. z o.o. report to view the information.
Incorporation Date:
April 20, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Provisus Badania Kliniczne Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
54.68%
Total operating revenue
54.66%
Operating profit (EBIT)
403.52%
EBITDA
332.24%
Net Profit (Loss) for the Period
400.57%
Total assets
341.21%
Total equity
685.8%
Operating Profit Margin (ROS)
12.93%
Net Profit Margin
12.17%
Return on Equity (ROE)
-35.08%
Quick Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?